Lista de obras - Vincenzo Cerullo - Dominio Público Uruguay

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma.

artículo científico publicado en 2017

AKT participates in endothelial dysfunction in hypertension

artículo científico publicado en 2004

Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer ⬇️

artículo científico publicado el 7 de agosto de 2012

Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models

artículo científico publicado en 2009

Antigen-specific tolerance of human alpha1-antitrypsin induced by helper-dependent adenovirus

artículo científico publicado en 2007

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment

artículo científico publicado en 2018

Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model

article

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

artículo científico publicado en 2013

Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors

artículo científico publicado en 2014

Artificially cloaked viral nanovaccine for cancer immunotherapy

artículo científico publicado en 2019

Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors

artículo científico publicado en 2013

Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia B

artículo científico publicado en 2009

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

artículo científico publicado en 2019

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging

artículo científico publicado en 2013

Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.

artículo científico publicado en 2010

Capsid-modified adenoviral vectors for improved muscle-directed gene therapy

artículo científico publicado en 2012

Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans

artículo científico publicado en 2012

Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma

scientific article published on 27 November 2019

Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectors

artículo científico publicado en 2007

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus

artículo científico publicado en 2010

Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates

artículo científico publicado en 2007

Design and application of oncolytic viruses for cancer immunotherapy

artículo científico publicado en 2019

Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction

artículo científico publicado en 2020

Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy

artículo científico publicado en 2020

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity

artículo científico publicado en 2016

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery

artículo científico publicado en 2020

Generation of helper-dependent adenoviral vectors by homologous recombination

artículo científico publicado en 2002

Genetic diversity and tumor immunesurveillance

artículo científico publicado en 2013

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

scientific article published on 23 October 2019

Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice

article

Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir

artículo científico publicado en 2010

Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.

artículo científico publicado en 2007

Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus

artículo científico publicado en 2015

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

artículo científico publicado en 2011

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders

artículo científico publicado en 2013

Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus ⬇️

artículo científico publicado el 26 de julio de 2011

Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system

artículo científico publicado en 2005

Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles.

artículo científico publicado en 2017

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures

artículo científico publicado en 2009

MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.

artículo científico publicado en 2010

NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.

artículo científico publicado en 2011

Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity

artículo científico publicado en 2016

Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients ⬇️

artículo científico publicado el 2 de abril de 2013

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

scientific article published on 10 July 2019

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

artículo científico publicado en 2010

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.

artículo científico publicado en 2015

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

artículo científico publicado en 2012

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

artículo científico publicado en 2018

Oncolytic viruses for induction of anti-tumor immunity

artículo científico publicado en 2012

Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks ⬇️

artículo científico

PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile

artículo científico publicado en 2005

Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy

article

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

scholarly article by Erkko Ylösmäki published in September 2018

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors

artículo científico publicado en 2010

Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver

artículo científico publicado en 2009

Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.

artículo científico publicado en 2009

Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin

artículo científico publicado en 2008

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

artículo científico publicado en 2011

Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model

artículo científico publicado en 2016

Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system

artículo científico publicado en 2012

Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4 ⬇️

artículo científico publicado el 10 de noviembre de 2011

The evolution of adenoviral vectors through genetic and chemical surface modifications

artículo científico publicado en 2014

Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors.

artículo científico publicado en 2007

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 - Support for clinical studies on advanced cancer treatment.

artículo científico publicado en 2017

Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes

artículo científico publicado en 2016

Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma

scientific article published on 27 August 2020

Lista de obras de Vincenzo Cerullo

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma.

AKT participates in endothelial dysfunction in hypertension

Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer ⬇️

Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models

Antigen-specific tolerance of human alpha1-antitrypsin induced by helper-dependent adenovirus

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment

Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors

Artificially cloaked viral nanovaccine for cancer immunotherapy

Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors

Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia B

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging

Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.

Capsid-modified adenoviral vectors for improved muscle-directed gene therapy

Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans

Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma

Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectors

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus

Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates

Design and application of oncolytic viruses for cancer immunotherapy

Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction

Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery

Generation of helper-dependent adenoviral vectors by homologous recombination

Genetic diversity and tumor immunesurveillance

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice

Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir

Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.

Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders

Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus ⬇️

Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system

Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles.

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures

MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.

NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.

Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity

Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients ⬇️

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Oncolytic viruses for induction of anti-tumor immunity

Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks ⬇️

PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile

Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors

Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver

Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.

Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model

Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system

Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4 ⬇️

The evolution of adenoviral vectors through genetic and chemical surface modifications

Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors.

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 - Support for clinical studies on advanced cancer treatment.

Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes

Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma